UroGen Pharma (URGN) Amortizatization of Intangibles (2019 - 2026)

UroGen Pharma's Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Amortizatization of Intangibles rose 155.04% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 51.87% YoY) and the FY2025 annual result came in at $476000.0, down 83.54% from the prior year.
• Amortizatization of Intangibles was $2.0 million for Q1 2026 at UroGen Pharma, up from -$1.3 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $2.0 million in Q1 2026 and bottomed at -$1.3 million in Q4 2025.
• A 5-year average of $508062.5 and a median of $335500.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2022 — Amortizatization of Intangibles slumped 4610.0% — and 2024, when it soared 2420.75%.
• UroGen Pharma's Amortizatization of Intangibles stood at $677000.0 in 2022, then plunged by 92.17% to $53000.0 in 2023, then surged by 2420.75% to $1.3 million in 2024, then plunged by 199.1% to -$1.3 million in 2025, then surged by 249.09% to $2.0 million in 2026.
• Business Quant data shows URGN's Amortizatization of Intangibles at $2.0 million in Q1 2026, -$1.3 million in Q4 2025, and $1.0 million in Q3 2025.